TOPIC

Investigating the therapeutic approaches in immune-mediated inflammatory skin diseases.

VISION

Improved quality of life of people with immune-mediated inflammatory skin diseases.

MISSION

Assessing and addressing the risks associated with JAK inhibitors in immune-mediated inflammatory skin diseases.

PROJECT TITLE 1

Investigating the cardiovascular and venous thromboembolic risk with JAK inhibitors in immune-mediated inflammatory skin diseases: Systematic Review and Meta-analysis.

PROJECT TITLE 2

Investigating the risk of inflammatory bowel disease in patients treated with IL-17 inhibitors: Systematic Review and Meta-analysis.